SEC 13F Intelligence

Newedge Advisors, LLC / LLY

Newedge Advisors, LLC’s Eli Lilly & Co Position

Does Newedge Advisors, LLC own Eli Lilly & Co (LLY)? Yes — 184.1K shares worth $169M (+0.61% of its 13F portfolio) as of Q2 2026, up from 176.4K shares the prior filed quarter.

Position Value
$169M
Q2 2026
Shares
184.1K
% of Portfolio
+0.61%
Quarters Held
30
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $1MQ4 ’18Q1 ’19: $2MQ2 ’19: $1MQ3 ’19: $3MQ4 ’19: $4MQ4 ’19Q1 ’20: $5MQ2 ’20: $6MQ3 ’20: $21MQ4 ’20: $6MQ4 ’20Q1 ’21: $6MQ2 ’21: $7MQ3 ’21: $9MQ4 ’21: $13MQ4 ’21Q1 ’22: $15MQ2 ’22: $20MQ3 ’22: $20MQ4 ’22: $12MQ4 ’22Q1 ’23: $23MQ2 ’23: $32MQ3 ’23: $39MQ4 ’23: $60MQ4 ’23Q1 ’24: $83MQ2 ’24: $112MQ3 ’24: $108MQ4 ’24: $93MQ4 ’24Q1 ’25: $101MQ2 ’25: $99MQ3 ’25: $97MQ4 ’25: $190MQ4 ’25Q2 ’26: $169Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 2026184.1K$169M+0.61%
Q4 2025176.4K$190M+0.69%
Q3 2025126.5K$97M+0.44%
Q2 2025126.7K$99M+0.51%
Q1 2025121.9K$101M+0.60%
Q4 2024120.7K$93M+0.56%
Q3 2024122.1K$108M+0.70%
Q2 2024123.2K$112M+0.81%
Q1 2024106.8K$83M+0.72%
Q4 202399.8K$60M+0.57%
Q3 202373.5K$39M+0.43%
Q2 202367.5K$32M+0.36%
Q1 202365.5K$23M+0.29%
Q4 202268.7K$12M+0.32%
Q3 202261.2K$20M+0.32%
Q2 202262.5K$20M+0.34%
Q1 202253.1K$15M+0.24%
Q4 202148.3K$13M+0.20%
Q3 202137.8K$9M+0.22%
Q2 202132.0K$7M+0.20%
Q1 202131.4K$6M+0.17%
Q4 202036.4K$6M+0.20%
Q3 2020143.1K$21M+0.74%
Q2 202037.9K$6M+0.24%
Q1 202036.1K$5M+0.24%
Q4 201931.1K$4M+0.16%
Q3 201931.2K$3M+0.15%
Q2 201912.1K$1M+0.08%
Q1 201911.9K$2M+0.10%
Q4 201812.1K$1M+0.09%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Newedge Advisors, LLC’s full portfolio or all institutional holders of LLY.